BioCentury | Feb 15, 2016
Emerging Company Profile

Platelet portrait

thromboDx B.V. has found a new repository to mine for disease diagnosis and treatment response: platelets. The company's most advanced programs are for cancer, where the technology could be easier to use and provide a...
BC Innovations | Aug 7, 2014
Tools & Techniques

Getting personal with CTCs

One of oncology's goals is to tailor cancer treatments for individual patients, which requires technologies to predict what drugs will work for a patient and monitor how a tumor changes over time. A team from...
BC Innovations | Dec 19, 2013
Translation in Brief

Translational tidbits

Consorting with academia GlaxoSmithKline plc has set up an immuno-oncology consortium that invites academics from six cancer centers to view its nonpublic early pipeline programs and share ideas for new therapeutic candidates. The Oncology Clinical...
BC Week In Review | Nov 18, 2013
Company News

ApoCell, Fraunhofer Institute for Cell Therapy and Immunology (IZI) deal

ApoCell established its ApoCell Europe GmbH European division, which partnered with not-for-profit Fraunhofer IZI to develop ApoCell's ApoStream . The detection device using dielectrophoresis field flow fractionation to isolate and recover circulating tumor cells (CTCs). The...
BC Week In Review | Apr 30, 2012
Clinical News

ApoStream diagnostic data

Data from blood samples of patients with HCC showed that ApoCell's ApoStream isolated a greater number of CTCs compared to Veridex LLC's CellSearch Circulating Tumor Cell Kit . Data were presented at the American Association for...
Items per page:
1 - 5 of 5